Capital Reduction Following Rehabilitation Plan Approval
-
Capital reduction decided following rehabilitation plan approval by Seoul Bankruptcy Court on May 12, 2026
-
Sequential implementation of debt-to-equity swap (May 19), share consolidation (May 27), and third-party allotment capital increase (May 28)
-
Fractional shares under 1 share from consolidation will be cancelled without compensation per court approval
-
Specific reduction ratio, capital changes, and other figures were not disclosed
KOSDAQ Filing Information
-
-
Current Report (Capital Reduction Decision)
-
Company: UNION KOREA PHARM (080720)
-
Submission: UNION KOREA PHARM CO.,Ltd
-
-
Shares: 7,912,828
-
Price: 2,725 KRW
-
Market Cap: 21.6 B KRW